𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Correlativity study on mammographic features and c-erbB-2 of breast cancer

✍ Scribed by Jie Ma; Min Zuo; Guoping Sun; Da Zang; Xiaomei Wang; Jianmin Xu


Publisher
Springer
Year
2006
Tongue
English
Weight
265 KB
Volume
5
Category
Article
ISSN
1610-1979

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


Retrospective c-erbB-2 immunostaining in
✍ M. Jorda; P. Ganjei; M. Nadji πŸ“‚ Article πŸ“… 1994 πŸ› John Wiley and Sons 🌐 English βš– 334 KB

## Abstract Fifty fine‐needle aspiration cytologies of breast that were diagnosed as carcinomas were retrieved from the files and retrospectively evaluated for the expression of __c__‐__erb__B‐2 oncoprotein using standard immunocytochemical methods. Corresponding histologic sections of all tumors w

c-erbB-2 expression in FNAB smears and m
✍ G. Troncone; L. Panico; A. Vetrani; B. de Divitiis; P. Zeppa; F. Fulciniti; G. P πŸ“‚ Article πŸ“… 1996 πŸ› John Wiley and Sons 🌐 English βš– 568 KB

Most of the data regarding the signijcance of c-erbB-2 oncogene expression as a prognostic marker in breast cancer have been generated in many large retrospective studies by retrieving the corresponding oncoprotein in archival parafin em bedded sections. Recent@. employing fresh breast cancer cells

Cytoplasmic staining of c-erbB-2 is not
✍ Susan L. Taylor; Angela Platt-Higgins; Philip S. Rudland; John H. R. Winstanley; πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 French βš– 223 KB πŸ‘ 2 views

The cell-surface receptor tyrosine kinase protein c-erbB-2 is immunocytochemically detected as membrane staining on the surface of cancer cells in 20-30% of cases of breast cancer, and its presence has been associated with poor prognosis for the patient. However, there have been numerous reports of